EsoBiotec is a biotechnology company developing innovative therapeutics to fight cancer. Our mission is to empower the human body to tackle cancer by bringing in vivo engineering of cells to patients. We aim to develop cost-effective and off-the-shelf therapeutics and providing state-of-the-art cell therapies to maximise accessibility. Our disruptive approach holds the potential to transform the current standard of cell and gene therapies for cancer treatment.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Rue André Dumont 5, Mont-Saint-Guibert,1435,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Gene therapy, Biotechnology, Oncology, Cell therapy, Cancer, in vivo engineering, virology, Immunology.
- HQ
- Mont-Saint-Guibert
Esobiotec Questions
Esobiotec's LinkedIn profile is https://be.linkedin.com/company/esobiotec
Esobiotec has
15 employees.
View email and phone details for 15
employees at Esobiotec.
Esobiotec's industry is
Biotechnology Research
Esobiotec's top competitors are
Celyad Oncology,
Astrivax Therapeutics,
Novadip Biosciences S.a.,
Epics Therapeutics,
Theratrame,
Invivo Partners,
Umoja Biopharma,
Capstan Therapeutics,
Thuja Capital,
Astrazeneca.
Esobiotec's categories are Biotechnology Research
Esobiotec's founding year is 2020
